Total Payments
$442,194
2023 Payments
$13,101
Companies
67
Transactions
1,359
Medicare Patients
1,231
Medicare Billing
$123,551
Payment Breakdown by Category
Other$319,538 (72.3%)
Travel$45,199 (10.2%)
Consulting$33,441 (7.6%)
Food & Beverage$27,460 (6.2%)
Research$16,133 (3.6%)
Education$423.60 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $319,538 | 148 | 72.3% |
| Travel and Lodging | $45,199 | 200 | 10.2% |
| Consulting Fee | $33,441 | 16 | 7.6% |
| Food and Beverage | $27,460 | 980 | 6.2% |
| Unspecified | $16,133 | 1 | 3.6% |
| Education | $423.60 | 14 | 0.1% |
Payments by Type
General
$426,061
1,358 transactions
Research
$16,133
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $269,382 | 490 | $0 (2023) |
| GENZYME CORPORATION | $66,455 | 107 | $0 (2020) |
| Genentech USA, Inc. | $42,347 | 62 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $20,691 | 85 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $16,402 | 14 | $0 (2022) |
| Amgen Inc. | $16,301 | 73 | $0 (2022) |
| Celgene Corporation | $1,795 | 18 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,202 | 50 | $0 (2022) |
| Allergan, Inc. | $732.05 | 42 | $0 (2022) |
| UCB, Inc. | $599.49 | 39 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13,101 | 21 | Biogen, Inc. ($13,101) |
| 2022 | $24,276 | 120 | Biogen, Inc. ($22,082) |
| 2021 | $66,019 | 215 | Biogen, Inc. ($55,021) |
| 2020 | $26,785 | 171 | Biogen, Inc. ($20,647) |
| 2019 | $81,218 | 283 | Biogen, Inc. ($44,043) |
| 2018 | $96,257 | 250 | Biogen, Inc. ($62,463) |
| 2017 | $134,538 | 299 | Biogen, Inc. ($52,026) |
All Payment Transactions
1,359 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/20/2023 | Biogen, Inc. | VUMERITY (Drug) | Travel and Lodging | In-kind items and services | $195.00 | General |
| Category: Neurology | ||||||
| 06/20/2023 | Biogen, Inc. | VUMERITY (Drug) | Travel and Lodging | Cash or cash equivalent | $160.00 | General |
| Category: Neurology | ||||||
| 06/07/2023 | Biogen, Inc. | VUMERITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,646.00 | General |
| Category: Neurology | ||||||
| 06/07/2023 | Biogen, Inc. | VUMERITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,890.00 | General |
| Category: Neurology | ||||||
| 06/07/2023 | Biogen, Inc. | VUMERITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,512.00 | General |
| Category: Neurology | ||||||
| 06/07/2023 | Biogen, Inc. | VUMERITY (Drug) | Travel and Lodging | In-kind items and services | $163.00 | General |
| Category: Neurology | ||||||
| 06/07/2023 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $82.17 | General |
| Category: Neurology | ||||||
| 06/07/2023 | Biogen, Inc. | VUMERITY (Drug) | Travel and Lodging | Cash or cash equivalent | $16.00 | General |
| Category: Neurology | ||||||
| 06/06/2023 | Biogen, Inc. | VUMERITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,024.00 | General |
| Category: Neurology | ||||||
| 06/06/2023 | Biogen, Inc. | VUMERITY (Drug) | Travel and Lodging | In-kind items and services | $777.00 | General |
| Category: Neurology | ||||||
| 06/06/2023 | Biogen, Inc. | VUMERITY (Drug) | Travel and Lodging | In-kind items and services | $304.00 | General |
| Category: Neurology | ||||||
| 06/06/2023 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $88.64 | General |
| Category: Neurology | ||||||
| 06/06/2023 | Biogen, Inc. | VUMERITY (Drug) | Travel and Lodging | Cash or cash equivalent | $53.00 | General |
| Category: Neurology | ||||||
| 06/06/2023 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $51.81 | General |
| Category: Neurology | ||||||
| 06/06/2023 | Biogen, Inc. | VUMERITY (Drug) | Travel and Lodging | Cash or cash equivalent | $46.00 | General |
| Category: Neurology | ||||||
| 06/06/2023 | Biogen, Inc. | VUMERITY (Drug) | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| Category: Neurology | ||||||
| 06/06/2023 | Biogen, Inc. | VUMERITY (Drug) | Travel and Lodging | Cash or cash equivalent | $34.00 | General |
| Category: Neurology | ||||||
| 06/06/2023 | Biogen, Inc. | VUMERITY (Drug) | Travel and Lodging | Cash or cash equivalent | $6.00 | General |
| Category: Neurology | ||||||
| 04/04/2023 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $95.00 | General |
| 02/17/2023 | Biogen, Inc. | VUMERITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,890.00 | General |
| Category: Neurology | ||||||
| 02/17/2023 | Biogen, Inc. | VUMERITY (Drug) | Travel and Lodging | Cash or cash equivalent | $27.00 | General |
| Category: Neurology | ||||||
| 12/14/2022 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $82.49 | General |
| Category: Neurology | ||||||
| 11/28/2022 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Immunology | ||||||
| 11/22/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $87.31 | General |
| 11/22/2022 | Avion Pharmaceuticals | Dhivy (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Parkinson's disease | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACP-103-015 | ACADIA Pharmaceuticals Inc | $16,133 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 405 | 556 | $109,894 | $42,963 |
| 2021 | 4 | 415 | 590 | $94,974 | $43,885 |
| 2020 | 4 | 411 | 575 | $79,070 | $36,703 |
Total Patients
1,231
Total Services
1,721
Medicare Billing
$123,551
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 149 | 208 | $45,760 | $17,706 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 187 | 279 | $41,571 | $17,076 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $22,563 | $8,180 | 36.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 244 | 403 | $47,429 | $24,407 | 51.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 92 | 92 | $28,599 | $10,831 | 37.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 82 | $16,648 | $7,683 | 46.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $2,298 | $964.29 | 42.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 257 | 406 | $40,600 | $21,393 | 52.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 57 | 57 | $17,100 | $6,411 | 37.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 74 | 89 | $14,240 | $5,860 | 41.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 23 | 23 | $7,130 | $3,039 | 42.6% |
About Dr. William Grainger, MD
Dr. William Grainger, MD is a Neurology healthcare provider based in Gilbert, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003963679.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Grainger, MD has received a total of $442,194 in payments from pharmaceutical and medical device companies, with $13,101 received in 2023. These payments were reported across 1,359 transactions from 67 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($319,538).
As a Medicare-enrolled provider, Grainger has provided services to 1,231 Medicare beneficiaries, totaling 1,721 services with total Medicare billing of $123,551. Data is available for 3 years (2020–2022), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Gilbert, AZ
- Active Since 01/04/2007
- Last Updated 06/30/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1003963679
Products in Payments
- TYSABRI (Biological) $95,754
- TECFIDERA (Drug) $87,713
- AUBAGIO (Drug) $66,008
- VUMERITY (Drug) $57,650
- OCREVUS (Biological) $26,560
- NUPLAZID (Drug) $16,402
- Aimovig (Biological) $16,255
- Non-Covered Product (Drug) $16,049
- AJOVY (Drug) $13,596
- AJOVY (Biological) $2,918
- PLEGRIDY (Biological) $2,145
- Ozanimod (Drug) $1,428
- TROKENDI XR (Drug) $580.72
- BOTOX (Biological) $538.77
- APTIOM (Drug) $431.77
- AIMOVIG (Biological) $408.46
- Briviact (Drug) $340.70
- LEMTRADA (Drug) $322.53
- EMGALITY (Drug) $270.23
- AVONEX (Biological) $268.39
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Gilbert
Jonathan Hodgson, Do, DO
Neurology — Payments: $366,071
Neurology $366,071
Paarth Shah, M.d, M.D
Neurology — Payments: $238,823
Neurology $238,823
Kan Yu, Md,Phd, MD,PHD
Neurology — Payments: $39,149
Neurology $39,149
Brian Beck, Md, MD
Neurology — Payments: $17,029
Neurology $17,029
Dr. Mildred Dejesus, Md, MD
Neurology — Payments: $10,414
Neurology $10,414
Virgilio Salanga, Md, MD
Neurology — Payments: $1,516
Neurology $1,516